PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Medicine, Mayo Clinic, Rochester, MN, USA.\', \'Department of Biostatistics, Harvard T H Chan School of Public Health, Boston, MA, USA.\', \'MIT Media Lab, Massachusetts Institute of Technology, Cambridge, MA, USA.\', \'School of Life Sciences, Arizona State University, Phoenix, AZ, USA.\', \'Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA.\', \'Media and Data Science Research Lab, Adobe Inc Noidia, UP, India.\', \'Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, MN, USA.\', \'Department of Medicine, University of Pennsylvania, Philadelphia, PA, USA.\', \'Department of Medicine, Mayo Clinic, Rochester, MN, USA Kingsley.Thomas@mayo.edu.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1136/bmj.n1087
?:doi
?:hasPublicationType
?:journal
  • BMJ (Clinical research ed.)
is ?:pmid of
?:pmid
?:pmid
  • 33980718
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • Public health impact of delaying second dose of BNT162b2 or mRNA-1273 covid-19 vaccine: simulation agent based modeling study.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all